Kehl KL - Search Results

1

Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis.

Van Egeren D, Kohli K, Warner JL, Bedard PL, Riely G, Lepisto E, Schrag D, LeNoue-Newton M, Catalano P, Kehl KL, Michor F; AACR Project GENIE Consortium represented by Shawn Sweeney. Van Egeren D, et al. Among authors: kehl kl. Sci Rep. 2022 Nov 9;12(1):19055. doi: 10.1038/s41598-022-21448-1. Sci Rep. 2022. PMID: 36351964 Free PMC article.

2

Access to Accredited Cancer Hospitals Within Federal Exchange Plans Under the Affordable Care Act.

Kehl KL, Liao KP, Krause TM, Giordano SH. Kehl KL, et al. J Clin Oncol. 2017 Feb 20;35(6):645-651. doi: 10.1200/JCO.2016.69.9835. Epub 2017 Jan 9. J Clin Oncol. 2017. PMID: 28068172 Free PMC article.

3

Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act.

Kehl KL, Fullmer CP, Fu S, George GC, Hess KR, Janku F, Karp DD, Kato S, Kizer CK, Kurzrock R, Naing A, Pant S, Piha-Paul SA, Subbiah V, Tsimberidou AM, Hong DS. Kehl KL, et al. Clin Cancer Res. 2017 Aug 1;23(15):4155-4162. doi: 10.1158/1078-0432.CCR-16-3027. Epub 2017 Jul 20. Clin Cancer Res. 2017. PMID: 28729355 Free PMC article.

4

Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer.

Kehl KL, Arora NK, Schrag D, Ayanian JZ, Clauser SB, Klabunde CN, Kahn KL, Fletcher RH, Keating NL. Kehl KL, et al. J Natl Cancer Inst. 2014 Sep 13;106(10):dju216. doi: 10.1093/jnci/dju216. Print 2014 Oct. J Natl Cancer Inst. 2014. PMID: 25217775 Free PMC article.

5

Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer.

Kehl KL, Lathan CS, Johnson BE, Schrag D. Kehl KL, et al. J Natl Cancer Inst. 2019 Apr 1;111(4):431-434. doi: 10.1093/jnci/djy202. J Natl Cancer Inst. 2019. PMID: 30576459 Free PMC article.

6

Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancer.

Kehl KL, Yang S, Awad MM, Palmer N, Kohane IS, Schrag D. Kehl KL, et al. Cancer Immunol Immunother. 2019 Jun;68(6):917-926. doi: 10.1007/s00262-019-02321-z. Epub 2019 Mar 15. Cancer Immunol Immunother. 2019. PMID: 30877325 Free PMC article.

7

Assessment of Deep Natural Language Processing in Ascertaining Oncologic Outcomes From Radiology Reports.

Kehl KL, Elmarakeby H, Nishino M, Van Allen EM, Lepisto EM, Hassett MJ, Johnson BE, Schrag D. Kehl KL, et al. JAMA Oncol. 2019 Oct 1;5(10):1421-1429. doi: 10.1001/jamaoncol.2019.1800. JAMA Oncol. 2019. PMID: 31343664 Free PMC article.

8

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression.

Aguilar EJ, Ricciuti B, Gainor JF, Kehl KL, Kravets S, Dahlberg S, Nishino M, Sholl LM, Adeni A, Subegdjo S, Khosrowjerdi S, Peterson RM, Digumarthy S, Liu C, Sauter J, Rizvi H, Arbour KC, Carter BW, Heymach JV, Altan M, Hellmann MD, Awad MM. Aguilar EJ, et al. Among authors: kehl kl. Ann Oncol. 2019 Oct 1;30(10):1653-1659. doi: 10.1093/annonc/mdz288. Ann Oncol. 2019. PMID: 31435660 Free article.

9

Insurance Networks and Access to Affordable Cancer Care.

Kehl KL, Keating NL, Giordano SH, Schrag D. Kehl KL, et al. J Clin Oncol. 2020 Feb 1;38(4):310-315. doi: 10.1200/JCO.19.01484. Epub 2019 Dec 5. J Clin Oncol. 2020. PMID: 31804867 Free PMC article. Review. No abstract available.

10

Patterns of care for older patients with stage IV non-small cell lung cancer in the immunotherapy era.

Kehl KL, Hassett MJ, Schrag D. Kehl KL, et al. Cancer Med. 2020 Mar;9(6):2019-2029. doi: 10.1002/cam4.2854. Epub 2020 Jan 27. Cancer Med. 2020. PMID: 31989786 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page